Margaret Cartiera

Vice President & Fund Manager at Connecticut Innovations, Inc.

Margaret Cartiera

Margaret Cartiera

Vice President & Fund Manager at Connecticut Innovations, Inc.

Biography

Margaret supports the initiation and management of the Connecticut Bioscience Innovation Fund and other bioscience initiatives at CT Innovations. She contributes to fund strategy and is responsible for interacting with fund applicants, conducting due diligence activities, and assisting portfolio organizations.

Margaret is formally trained as a biomedical engineer and has expertise in regulatory affairs, competitive intelligence, market research and operational management. She has more than 15 years of experience in the investment, medical device, pharmaceutical and biotech fields, having worked for companies both large and small, such as Siemens Medical Systems and Carigent Therapeutics.

Margaret has held various leadership positions and has been a trusted adviser and consultant to startup companies and venture capital firms.

Overview
RelSci Relationships

106

Contact Data
Trying to get in touch with Margaret Cartiera? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Margaret Cartiera likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Connecticut Innovations, Inc.

Relationship likelihood: Average

Director-Strategic Initiatives at Connecticut Innovations, Inc.

Relationship likelihood: Average

Chief Operating Officer & Director at Sustainable Real Estate Solutions, Inc.

Relationship likelihood: Average

Director at Connecticut Innovations, Inc.

Relationship likelihood: Average

Managing Director, Investments at Connecticut Innovations, Inc.

Relationship likelihood: Average

Managing Director, Investments at Connecticut Innovations, Inc.

Relationship likelihood: Average

Senior Managing Director at Aventri, Inc.

Relationship likelihood: Average

Senior Managing Director, Investments at Connecticut Innovations, Inc.

Relationship likelihood: Average

Senior Managing Director, Investments at Connecticut Innovations, Inc.

Relationship likelihood: Average

Senior Managing Director, Investments at Connecticut Innovations, Inc.

Relationship likelihood: Average

Paths to Margaret Cartiera
Potential Connections via
Relationship Science
You
Margaret Cartiera
Vice President & Fund Manager at Connecticut Innovations, Inc.
Education
MS, BioEngineering

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Ph.D Biomedical Engineering

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

BS Biomedical Engineering

Rensselaer Polytechnic Institute, or RPI, is a private research university located in Troy, New York, with two additional campuses in Hartford and Groton, Connecticut. It was founded in 1824 by Stephen van Rensselaer and Amos Eaton for the "application of science to the common purposes of life" and is the oldest technological university in the English-speaking world.

Career History
Vice President & Fund Manager
2013 - ?

CI typically invests between $500,000 and $1,000,000 per round into our companies. Our focus in on building technology and technology-enabled enterprises in Connecticut, in industries where Connecticut has a strong position and competitive advantage. To date, primarily invested in software and IT, bioscience, clean tech, digital media and technologies important to advanced manufacturing such as photonics and advanced materials. We actively seek pre-seed, seed and early stage (Series A) investments.We look for components of the following three characteristics in evaluating investment opportunities, each of which we believe are necessary to build extraordinary companies:ManagementMarketTechnologyCI accomplishes their mission primarily by making equity investments in emerging Connecticut technology companies, providing essential, non-financial support to entrepreneurs and conducting initiatives that address specific needs of Connecticut's technology sector

Grad Research Assistant/Research Associate
2002 - 2007

Yale University School of Medicine provides higher education and professional qualifications related to the health industry. It offers the Doctor of Medicine (M.D.) degree and a Master of Medical Science (M.M.Sc.) degree through the Yale Physician Associate Program for prospective physician assistants. Public health degrees are administered through the Yale School of Public Health. It also provides joint degree programs with other disciplines at Yale, including the M.D/Juris Doctor (J.D.) in conjunction with Yale Law School; the M.D./Master of Business Administration (M.B.A.) in conjunction with the Yale School of Management; the M.D./Master of Public Health (M.P.H.) in conjunction with the Yale School of Public Health; science or engineering in conjunction with the Yale Graduate School of Arts and Sciences (M.D./Ph.D.); and the M.D./Master of Divinity (M.Div) in conjunction with Yale Divinity School. Yale University School of Medicine carries out its practical teaching through the Yale-New Haven Hospital. It includes 62 National Academy of Sciences members, 40 Institute of Medicine investigators, and 16 Howard Hughes Medical Institute investigators. It has 718 students and 2,451 academic staff. It was founded in 1810 as The Medical Institution of Yale College, and formally opened its doors in 1813. Yale University School of Medicine is based in New Haven, Connecticut.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Margaret Cartiera. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Margaret Cartiera's profile does not indicate a business or promotional relationship of any kind between RelSci and Margaret Cartiera.